Evaluation of Traditional Laboratory Markers as Predictors of Renal Flares: A Post-hoc Analysis of Four Phase III Clinical Trials of SLE

被引：0
作者：
Jagerback, Sandra [1 ]
Gomez, Alvaro [1 ]
Parodis, Ioannis [2 ]
机构：
[1] Karolinska Inst, Div Rheumatol, Dept Med, Stockholm, Sweden
[2] Karolinska Inst, Stockholm, Sweden
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0540
引用
收藏
页码：1090 / 1093
页数：4
相关论文
共 50 条
  • [21] CAN THE SLE-DAS SUBSTITUTE BILAG TO MEASURE LUPUS DISEASE ACTIVITY IN CLINICAL TRIALS? POST-HOC ANALYSIS OF THE BLISS-76 TRIAL
    Jesus, D.
    Matos, A.
    Henriques, C.
    Doria, A.
    Ines, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 634 - 635
  • [22] Association Between Knee Osteoarthritis Pain and Concomitant Drug Use: A Post-hoc Analysis of Two Phase 3 Clinical Trials
    Miller, Claire
    Baker, Matthew
    Alexandersen, Peter
    Mondragon, Alejandro
    Adrian, Ida Sofie
    Karsdal, Morten
    Andersen, Jeppe
    Bihlet, Asger
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3950 - 3952
  • [23] Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis
    Glauser, Tracy
    Laurenza, Antonio
    Yang, Haichen
    Williams, Betsy
    Ma, Tony
    Fain, Randi
    EPILEPSY RESEARCH, 2016, 119 : 34 - 40
  • [24] MYOSITIS AUTOANTIBODIES AS PREDICTORS OF RESPONSE TO IVIG. POST-HOC ANALYSIS OF A LARGE, RANDOMIZED, PLACEBO-CONTROLLED PHASE III TRIAL
    Charles-Schoeman, Christina
    Schessl, Joachim
    Clodi, Elisabeth
    Aggarwal, Rohit
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 548 - 549
  • [25] Evaluation of Patient-Rated Stiffness Associated With Fibromyalgia: A Post-Hoc Analysis of 4 Pooled, Randomized Clinical Trials of Duloxetine
    Bennett, Robert
    Russell, I. Jon
    Choy, Ernest
    Spaeth, Michael
    Mease, Philip
    Kajdasz, Daniel
    Walker, Daniel
    Wang, Fujun
    Chappell, Amy
    CLINICAL THERAPEUTICS, 2012, 34 (04) : 824 - 837
  • [26] Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trials
    Agnieszka Król
    Robert Palmér
    Virginie Rondeau
    Stephen Rennard
    Ulf G. Eriksson
    Alexandra Jauhiainen
    Respiratory Research, 21
  • [27] FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS
    Emery, Paul
    Downie, Bryan
    Liu, Jinfeng
    Hawtin, Rachael E.
    Curtis, Jeffrey R.
    Burmester, Gerd R.
    RHEUMATOLOGY, 2022, 61
  • [28] Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trials
    Krol, Agnieszka
    Palmer, Robert
    Rondeau, Virginie
    Rennard, Stephen
    Eriksson, Ulf G.
    Jauhiainen, Alexandra
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [29] FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS
    Emery, P.
    Downie, B.
    Liu, J.
    Hawtin, R.
    Curtis, J. R.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 502 - 502
  • [30] A novel endpoint for exacerbations in asthma to accelerate clinical development: a post-hoc analysis of randomised controlled trials
    Fuhlbrigge, Anne L.
    Bengtsson, Thomas
    Peterson, Stefan
    Jauhiainen, Alexandra
    Eriksson, Goran
    Da Silva, Carla A.
    Johnson, Anthony
    Sethi, Tariq
    Locantore, Nicholas
    Tal-Singer, Ruth
    Fageras, Malin
    LANCET RESPIRATORY MEDICINE, 2017, 5 (07) : 577 - 590
12345